Immunotherapeutic aryl amides

Details Immunotherapeutic aryl amides Immunotherapeutic aryl amides

1996-10-15

1998-04-07

Fan, Jane

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514535, 514617, 514619, 514622, A61K 31235, A61K 31165

Patent

active

057365709

ABSTRACT:
Novel aryl amides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.

REFERENCES:
patent: 5463063 (1995-10-01), Muller

Affiliated with

Also associated with

Rating

Immunotherapeutic aryl amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutic aryl amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic aryl amides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-14092